Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
1
|
Banff 07 classification of renal allograft pathology: updates and future directions.
|
Am J Transplant
|
2008
|
8.09
|
2
|
Banff '05 Meeting Report: differential diagnosis of chronic allograft injury and elimination of chronic allograft nephropathy ('CAN').
|
Am J Transplant
|
2007
|
5.39
|
3
|
Understanding the causes of kidney transplant failure: the dominant role of antibody-mediated rejection and nonadherence.
|
Am J Transplant
|
2011
|
4.06
|
4
|
Antibody-mediated microcirculation injury is the major cause of late kidney transplant failure.
|
Am J Transplant
|
2009
|
3.43
|
5
|
Banff 2013 meeting report: inclusion of c4d-negative antibody-mediated rejection and antibody-associated arterial lesions.
|
Am J Transplant
|
2014
|
3.43
|
6
|
Banff '09 meeting report: antibody mediated graft deterioration and implementation of Banff working groups.
|
Am J Transplant
|
2010
|
3.29
|
7
|
Quality assurance in immunohistochemistry: results of an interlaboratory trial involving 172 pathologists.
|
Am J Surg Pathol
|
2002
|
3.05
|
8
|
Microarray analysis of rejection in human kidney transplants using pathogenesis-based transcript sets.
|
Am J Transplant
|
2007
|
2.25
|
9
|
De novo donor-specific antibody at the time of kidney transplant biopsy associates with microvascular pathology and late graft failure.
|
Am J Transplant
|
2009
|
2.24
|
10
|
FOXP3 expression in human kidney transplant biopsies is associated with rejection and time post transplant but not with favorable outcomes.
|
Am J Transplant
|
2008
|
1.94
|
11
|
A new diagnostic algorithm for antibody-mediated microcirculation inflammation in kidney transplants.
|
Am J Transplant
|
2012
|
1.93
|
12
|
Use of dermagraft, a cultured human dermis, to treat diabetic foot ulcers.
|
Diabetes Care
|
1996
|
1.91
|
13
|
NK cell transcripts and NK cells in kidney biopsies from patients with donor-specific antibodies: evidence for NK cell involvement in antibody-mediated rejection.
|
Am J Transplant
|
2010
|
1.62
|
14
|
The nature of biopsies with "borderline rejection" and prospects for eliminating this category.
|
Am J Transplant
|
2011
|
1.60
|
15
|
CXCR4/CXCL12 expression and signalling in kidney cancer.
|
Br J Cancer
|
2002
|
1.59
|
16
|
Molecular diagnosis of T cell-mediated rejection in human kidney transplant biopsies.
|
Am J Transplant
|
2013
|
1.57
|
17
|
Molecular and functional characterization of the small Ca(2+)-regulated K+ channel (rSK4) of colonic crypts.
|
Pflugers Arch
|
1999
|
1.38
|
18
|
Peritubular capillaritis in renal allografts: prevalence, scoring system, reproducibility and clinicopathological correlates.
|
Am J Transplant
|
2008
|
1.27
|
19
|
Molecular diagnosis of antibody-mediated rejection in human kidney transplants.
|
Am J Transplant
|
2013
|
1.25
|
20
|
Diagnosing rejection in renal transplants: a comparison of molecular- and histopathology-based approaches.
|
Am J Transplant
|
2009
|
1.19
|
21
|
Inflammation lesions in kidney transplant biopsies: association with survival is due to the underlying diseases.
|
Am J Transplant
|
2011
|
1.16
|
22
|
The transcriptome of the implant biopsy identifies donor kidneys at increased risk of delayed graft function.
|
Am J Transplant
|
2007
|
1.13
|
23
|
Lymphatic neoangiogenesis in human renal allografts: results from sequential protocol biopsies.
|
Am J Transplant
|
2007
|
1.13
|
24
|
Comparing microarray versus RT-PCR assessment of renal allograft biopsies: similar performance despite different dynamic ranges.
|
Am J Transplant
|
2008
|
1.10
|
25
|
Classical Hodgkin's disease. Clinical impact of the immunophenotype.
|
Am J Pathol
|
1997
|
1.08
|
26
|
Interpreting NK cell transcripts versus T cell transcripts in renal transplant biopsies.
|
Am J Transplant
|
2012
|
1.06
|
27
|
The transcriptome of human cytotoxic T cells: measuring the burden of CTL-associated transcripts in human kidney transplants.
|
Am J Transplant
|
2008
|
1.01
|
28
|
Cluster analysis of lesions in nonselected kidney transplant biopsies: microcirculation changes, tubulointerstitial inflammation and scarring.
|
Am J Transplant
|
2010
|
0.98
|
29
|
Tyramine amplification technique in routine immunohistochemistry.
|
J Histochem Cytochem
|
1997
|
0.98
|
30
|
Transcriptome analysis reveals heterogeneity in the injury response of kidney transplants.
|
Am J Transplant
|
2007
|
0.96
|
31
|
Expression of B cell and immunoglobulin transcripts is a feature of inflammation in late allografts.
|
Am J Transplant
|
2008
|
0.95
|
32
|
[Interlaboratory trial 2000 " Immunohistochemistry" of the German Society for Pathology and the Professional Association of German Pathologists].
|
Pathologe
|
2003
|
0.95
|
33
|
Transplanted human cord blood-derived unrestricted somatic stem cells improve left-ventricular function and prevent left-ventricular dilation and scar formation after acute myocardial infarction.
|
Heart
|
2008
|
0.93
|
34
|
Diagnostic impact of fluorescence in situ hybridization in the differentiation of hepatocellular adenoma and well-differentiated hepatocellular carcinoma.
|
J Mol Diagn
|
2001
|
0.93
|
35
|
The molecular phenotype of kidney transplants.
|
Am J Transplant
|
2010
|
0.92
|
36
|
Loss of solute carriers in T cell-mediated rejection in mouse and human kidneys: an active epithelial injury-repair response.
|
Am J Transplant
|
2010
|
0.91
|
37
|
The early course of kidney allograft rejection: defining the time when rejection begins.
|
Am J Transplant
|
2009
|
0.91
|
38
|
A blue kidney--chronic renal failure as a consequence of siderosis in paroxysmal nocturnal hemoglobinuria?
|
Clin Nephrol
|
2006
|
0.90
|
39
|
Defining the canonical form of T-cell-mediated rejection in human kidney transplants.
|
Am J Transplant
|
2010
|
0.90
|
40
|
Banff fibrosis study: multicenter visual assessment and computerized analysis of interstitial fibrosis in kidney biopsies.
|
Am J Transplant
|
2014
|
0.90
|
41
|
Cardiovascular MRI predicts 5-year adverse clinical outcome in heart transplant recipients.
|
Am J Transplant
|
2014
|
0.88
|
42
|
Nodular B-cell aggregates associated with treatment refractory renal transplant rejection resolved by rituximab.
|
Am J Transplant
|
2006
|
0.87
|
43
|
The use of the family APGAR in screening for family dysfunction in a family practice center.
|
J Fam Pract
|
1987
|
0.85
|
44
|
Side effects of sirolimus.
|
Transplant Proc
|
2006
|
0.85
|
45
|
Banff Initiative for Quality Assurance in Transplantation (BIFQUIT): reproducibility of polyomavirus immunohistochemistry in kidney allografts.
|
Am J Transplant
|
2014
|
0.84
|
46
|
Familial low frequency hearing loss.
|
Laryngoscope
|
1971
|
0.82
|
47
|
Acute tubular injury in protocol biopsies of renal grafts: prevalence, associated factors and effect on long-term function.
|
Am J Transplant
|
2008
|
0.82
|
48
|
Histological characteristics of calcineurin inhibitor toxicity--there is no such thing as specificity!
|
Am J Transplant
|
2011
|
0.81
|
49
|
Nodular fasciitis, erythema migrans, and oligoarthritis: manifestations of Lyme borreliosis caused by Borrelia afzelii.
|
Scand J Rheumatol
|
2002
|
0.80
|
50
|
Correlation of bFGF expression in renal cell cancer with clinical and histopathological features by tissue microarray analysis and measurement of serum levels.
|
J Cancer Res Clin Oncol
|
2005
|
0.80
|
51
|
Dominant midfrequency hearing loss.
|
Ann Otol Rhinol Laryngol
|
1970
|
0.79
|
52
|
Psychosocial and psychopathologic influences on management and control of insulin-dependent diabetes.
|
Int J Psychiatry Med
|
1992
|
0.78
|
53
|
Complete sequencing and messenger ribonucleic acid expression analysis of the MEN I gene in adrenal cancer.
|
J Clin Endocrinol Metab
|
2000
|
0.78
|
54
|
Investigation into an unusual increase of human cases of Salmonella Goldcoast infection in Hungary in 2009.
|
Euro Surveill
|
2013
|
0.78
|
55
|
Complete sequencing and mRNA expression analysis of the MEN-I gene in adrenal myelolipoma.
|
Horm Metab Res
|
2000
|
0.77
|
56
|
An appeal for zero-time biopsies in renal transplantation.
|
Am J Transplant
|
2008
|
0.77
|
57
|
Protocol biopsy program after renal transplantation: structure and first results.
|
Transplant Proc
|
2002
|
0.77
|
58
|
Nephrotoxicity of selective COX-2 inhibitors.
|
J Rheumatol
|
2001
|
0.76
|
59
|
Donor Fas is not necessary for T-cell-mediated rejection of mouse kidney allografts.
|
Am J Transplant
|
2008
|
0.75
|
60
|
Complement inhibition in HLA-incompatible kidney transplants: persisting antibody-mediated injury despite marked decrease of clinical ABMR.
|
Am J Transplant
|
2015
|
0.75
|
61
|
Chimerism after solid organ transplantation.
|
Am J Transplant
|
2005
|
0.75
|
62
|
DHEA(S)--a novel marker in Cushing's disease.
|
Acta Neurochir (Wien)
|
2013
|
0.75
|
63
|
Compartment-specific quantitative gene expression analysis after laser microdissection from archival renal allograft biopsies.
|
Clin Nephrol
|
2005
|
0.75
|
64
|
MEN I gene mutations in sporadic adrenal adenomas.
|
Hum Genet
|
1999
|
0.75
|
65
|
Heterogeneous p27(Kip1) expression within primary renal cell cancers, their invasive margins and peritumoral renal parenchyma correlation with pathological and prognostic features.
|
Urol Int
|
2007
|
0.75
|
66
|
[Basic principles, planning and implementation of non-commercial clinical trials].
|
Ophthalmologe
|
2011
|
0.75
|
67
|
The use of the cytocentrifuge in the diagnosis of meningitis.
|
Am J Clin Pathol
|
1985
|
0.75
|
68
|
Acute renal failure in a kidney donor.
|
Am J Transplant
|
2012
|
0.75
|
69
|
[Embryonal rhabdomyosarcoma of the orbita].
|
Laryngorhinootologie
|
2006
|
0.75
|
70
|
Acanthosis nigricans, telangiectasia and diabetes mellitus.
|
Birth Defects Orig Artic Ser
|
1971
|
0.75
|